Drug details
Glatopa (glatiramer acetate injection)
type of Immunomodulators
Glatopa (glatiramer acetate injection) is an immunomodulator used to treat patients with relapsing forms of multiple sclerosis (MS), including those who have experienced a first clinical episode and have magnetic resonance imaging (MRI) features consistent with MS. Glatopa is generic version of Copaxone.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- itching,
- dark urine,
- vomiting,
- fever,
- shortness of breath,
- stomach pain,
- chest pain,
- dizziness,
- fainting,
- sore throat,
- mood changes,
- flushing,
- anxiety,
- depression,
- yellowing of the eyes or skin (jaundice),
- tremors,
- fast heartbeat,
- rash
- vision problems, and
- severe pain at the injection site,
- swelling of the feet or legs,
The following drugs are related to Glatopa, either as a replacement or used together:
- Lemtrada (alemtuzumab injection for intravenous infusion)
- Ampyra (dalfampridine extended-release tablets)
- Aubagio (teriflunomide tablets)
- Avonex (interferon beta-1a)
- Ozobax (baclofen oral solution)
- Fleqsuvy (baclofen oral suspension)
- Betaseron (interferon beta-1b)
- Mavenclad (cladribine tablets)
- Copaxone (glatiramer acetate)
- Tecfidera (dimethyl fumarate delayed release capsules)
- Extavia (interferon beta-1b kit)
- Gilenya (fingolimod capsules)
- Rebif (interferon beta-1a)
- Kesimpta (ofatumumab injection)
- Mayzent (siponimod tablets)
- Novantrone (mitoxantrone for injection concentrate)
- Tysabri (natalizumab)
- Tyruko (natalizumab-sztn injection)
- Zeposia (ozanimod capsules)
- Plegridy (peginterferon beta-1a injection for subcutaneous use)